- Home
- GDTC vs NTIP Comparison
GDTC vs NTIP Comparison
Compare GDTC & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- NTIP
- Stock Information
- Founded
- GDTC 2018
- NTIP 1990
- Country
- GDTC Singapore
- NTIP United States
- Employees
- GDTC N/A
- NTIP N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- NTIP Multi-Sector Companies
- Sector
- GDTC Health Care
- NTIP Miscellaneous
- Exchange
- GDTC Nasdaq
- NTIP Nasdaq
- Market Cap
- GDTC 21.5M
- NTIP 32.0M
- IPO Year
- GDTC 2023
- NTIP 1998
- Fundamental
- Price
- GDTC $1.89
- NTIP $1.42
- Analyst Decision
- GDTC Buy
- NTIP
- Analyst Count
- GDTC 1
- NTIP 0
- Target Price
- GDTC $5.00
- NTIP N/A
- AVG Volume (30 Days)
- GDTC 18.1K
- NTIP 35.4K
- Earning Date
- GDTC 01-01-0001
- NTIP 08-11-2025
- Dividend Yield
- GDTC N/A
- NTIP 7.07%
- EPS Growth
- GDTC N/A
- NTIP N/A
- EPS
- GDTC N/A
- NTIP N/A
- Revenue
- GDTC $368,838.00
- NTIP $250,000.00
- Revenue This Year
- GDTC $5.37
- NTIP N/A
- Revenue Next Year
- GDTC N/A
- NTIP N/A
- P/E Ratio
- GDTC N/A
- NTIP N/A
- Revenue Growth
- GDTC N/A
- NTIP N/A
- 52 Week Low
- GDTC $1.20
- NTIP $1.16
- 52 Week High
- GDTC $4.05
- NTIP $1.78
- Technical
- Relative Strength Index (RSI)
- GDTC 37.08
- NTIP 63.69
- Support Level
- GDTC $1.85
- NTIP $1.40
- Resistance Level
- GDTC $1.95
- NTIP $1.46
- Average True Range (ATR)
- GDTC 0.10
- NTIP 0.05
- MACD
- GDTC -0.02
- NTIP 0.00
- Stochastic Oscillator
- GDTC 28.00
- NTIP 78.95
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.